Novolog Pharm-Up 1966 Ltd Capital Reinvestment Ratio
Novolog Pharm-Up 1966 Ltd capital reinvestment ratio. Novolog Pharm-Up 1966 Ltd (NVLG) has a Capital Reinvestment Ratio of 1.41x as of September 2025, meaning it reinvests 1% of its operating cash flow (ILA15.42 Million) in capital expenditures (ILA21.78 Million). See NVLG free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Novolog Pharm-Up 1966 Ltd (2014–2024)
Capital reinvestment ratio of Novolog Pharm-Up 1966 Ltd from 2014 to 2024. This chart tracks Novolog Pharm-Up 1966 Ltd's Capital Reinvestment Ratio across 11 annual periods. See financial agility of Novolog Pharm-Up 1966 Ltd to measure the company's free cash flow as a share of total liabilities.
Novolog Pharm-Up 1966 Ltd Capital Reinvestment Ratio by Year (2014–2024)
Novolog Pharm-Up 1966 Ltd capital reinvestment ratio by year from 2014 to 2024. For the full cash flow conversion analysis, see Novolog Pharm-Up 1966 Ltd cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (ILA) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.37x | ILA158.52 Million | ILA58.74 Million | ▲ +4.4% |
| 2023 | 0.35x | ILA200.01 Million | ILA70.95 Million | ▼ -32.3% |
| 2022 | 0.52x | ILA132.65 Million | ILA69.49 Million | ▲ +42.6% |
| 2021 | 0.37x | ILA83.39 Million | ILA30.64 Million | ▼ -16.1% |
| 2020 | 0.44x | ILA58.48 Million | ILA25.61 Million | ▲ +77.6% |
| 2019 | 0.25x | ILA101.45 Million | ILA25.01 Million | ▼ -79.8% |
| 2018 | 1.22x | ILA23.96 Million | ILA29.27 Million | ▲ +202.4% |
| 2017 | 0.40x | ILA86.37 Million | ILA34.89 Million | ▼ -38.5% |
| 2016 | 0.66x | ILA20.28 Million | ILA13.32 Million | ▲ +700.7% |
| 2015 | 0.08x | ILA140.29 Million | ILA11.50 Million | ▲ +381.8% |
| 2014 | 0.02x | ILA160.59 Million | ILA2.73 Million | — |